Clinical trial on effects of homeopathic medicine made from cadamba on COVID-19
Phase 3
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/04/024947
- Lead Sponsor
- Dr Priti katre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 COVID affected individual (serologically positive) symptomatic, mild hospitalized
2 asymptomatic (serologically positive)
Exclusion Criteria
1.Malabsorption or inadequate oral intake
2.unexplained, chronic diarrhea, defined as more than 3 loose stool per day persisting for 2 weeks or more within the month prior to study entry.
3. Active malignancy or anticipated need for chemotherapy during the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method